Browsing by Author McIntyre, Peter

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Publication DateTitleAuthor(s)TypeSubject
27-Jan-2021Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia.Strachan, Roxanne; Homaira, Nusrat; Beggs, Sean; Bhuiyan, Mejbah U; Gilbert, Gwendolyn L; Lambert, Stephen B; Macartney, Kristine; Marshall, Helen; Martin, Andrew C; McCallum, Gabrielle B; McCullagh, Angela; McDonald, Tim; McIntyre, Peter; Oftadeh, Shahin; Ranganathan, Sarath; Suresh, Sadasivam; Wainwright, Claire E; Wilson, Angela; Wong, Melanie; Snelling, Thomas; Jaffé, AdamJournal Article- 
16-Oct-2023Erratum to "Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study" [Vaccine 41(1) (2023) 85-91].Homaira, Nusrat; Strachan, Roxanne; Quinn, Helen; Beggs, Sean; Bhuiyan, Mejbah; Bowen, Asha; Fawcett, Laura K; Gilbert, Gwendolyn L; Lambert, Stephen B; Macartney, Kristine; Marshall, Helen S; Martin, Andrew C; McCallum, Gabrielle; McCullagh, Angela; McDonald, Tim; Selvadurai, Hiran; McIntyre, Peter; Oftadeh, Shahin; Ranganathan, Sarath; Saunders, Thomas; Suresh, Sadasivam; Wainwright, Claire; Wilson, Angela; Wong, Melanie; Jaffe, Adam; Snelling, TomPublished Erratum- 
27-Jun-2022Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials.Leach, Amanda Jane; Wilson, Nicole; Arrowsmith, Beth; Beissbarth, Jemima; Mulholland, Edward Kim; Santosham, Mathuram; Torzillo, Paul John; McIntyre, Peter; Smith-Vaughan, Heidi; Chatfield, Mark D; Lehmann, Deborah; Binks, Michael; Chang, Anne B; Carapetis, Jonathan; Krause, Vicki; Andrews, Ross; Snelling, Tom; Skull, Sue A; Licciardi, Paul V; Oguoma, Victor M; Morris, Peter StanleyJournal Article- 
8-Mar-2021Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial.Leach, Amanda Jane; Mulholland, Edward Kim; Santosham, Mathuram; Torzillo, Paul John; McIntyre, Peter; Smith-Vaughan, Heidi; Wilson, Nicole; Arrowsmith, Beth; Beissbarth, Jemima; Chatfield, Mark D; Oguoma, Victor M; Morris, Peter StanleyJournal Article-